Rising Biochemistry, Genetics and Molecular Biology journals compared with their field
These are the Biochemistry, Genetics and Molecular Biology journals whose OJR rose faster than the median journal of their field between 2022 and 2025, by +10% or more relative to that median and by at least 2 standard errors. 141 journals qualify.
Between indicator years 2022 and 2025, the median OJR change among 871 eligible Biochemistry, Genetics and Molecular Biology journals was about -8%, taking the median on a log scale (the group ratio below).
Ordered by the lower bound of the relative-change range at two standard errors, highest first, then higher z (the signed difference in standard errors), then title. How trajectory is calculated (traj-v1)
| Journal | OJR 2022 → 2025 The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method. | Change relative to Biochemistry, Genetics and Molecular Biology median (2 SE range) | z (standard errors) |
|---|---|---|---|
| Signal Transduction and Targeted Therapy | 4.84 → 14.09 | +216.6% (+162.8% to +281.4%) | 12.4 |
| Crohn s & Colitis 360 | 0.41 → 1.02 | +171.3% (+109.2% to +252.0%) | 7.7 |
| Chinese Herbal Medicines | 0.91 → 2.05 | +143.9% (+94.0% to +206.6%) | 7.8 |
| Current Molecular Pharmacology | 0.71 → 1.60 | +145.6% (+82.3% to +231.0%) | 6.0 |
| Science | 4.27 → 7.42 | +88.9% (+73.0% to +106.3%) | 14.4 |
| The Breast | 0.72 → 2.00 | +202.4% (+58.9% to +475.8%) | 3.4 |
| Phytomedicine | 2.00 → 3.01 | +63.4% (+49.3% to +78.9%) | 10.9 |
| Cellular and Molecular Neurobiology | 1.14 → 1.87 | +79.3% (+48.8% to +116.1%) | 6.3 |
| Medizinische Genetik | 0.15 → 0.36 | +168.3% (+47.7% to +387.3%) | 3.3 |
| EBioMedicine | 2.21 → 3.24 | +59.4% (+42.1% to +78.7%) | 8.1 |
| Molecules and Cells | 0.83 → 1.44 | +87.7% (+40.6% to +150.4%) | 4.4 |
| Molecular Aspects of Medicine | 2.55 → 4.29 | +83.1% (+36.7% to +145.1%) | 4.1 |
| Trends in Pharmacological Sciences | 1.08 → 1.72 | +72.5% (+34.9% to +120.7%) | 4.4 |
| Redox Biology | 3.19 → 4.39 | +49.6% (+33.9% to +67.2%) | 7.3 |
| Biocell | 0.25 → 0.39 | +65.4% (+33.8% to +104.5%) | 4.8 |
| Journal of Nanobiotechnology | 2.73 → 3.75 | +49.0% (+33.4% to +66.6%) | 7.2 |
| Journal of the Canadian Association of Gastroenterology | 0.55 → 1.05 | +107.3% (+33.3% to +222.5%) | 3.3 |
| Microbiology | 0.80 → 1.30 | +77.5% (+33.1% to +136.6%) | 4.0 |
| Cell Communication and Signaling | 2.13 → 3.22 | +64.5% (+32.8% to +103.9%) | 4.6 |
| Toxicon | 0.57 → 0.80 | +53.8% (+31.6% to +79.8%) | 5.5 |
| Drug Design Development and Therapy | 1.59 → 2.18 | +48.8% (+31.2% to +68.8%) | 6.3 |
| Journal of Analysis and Testing | 1.08 → 1.66 | +67.7% (+30.6% to +115.2%) | 4.1 |
| Gut Microbes | 3.03 → 4.21 | +51.1% (+30.5% to +74.9%) | 5.6 |
| Lab Animal | 0.12 → 0.24 | +106.6% (+30.4% to +227.3%) | 3.2 |
| Current Genomics | 0.65 → 1.04 | +75.2% (+29.3% to +137.4%) | 3.7 |
| Cell Death Discovery | 1.85 → 2.53 | +48.5% (+29.0% to +70.9%) | 5.6 |
| Biomedicine & Pharmacotherapy | 2.22 → 2.79 | +36.5% (+28.1% to +45.4%) | 9.8 |
| International Journal of Pharmaceutical Investigation | 0.23 → 0.36 | +71.1% (+27.6% to +129.3%) | 3.7 |
| Analytical Sciences | 0.31 → 0.50 | +74.2% (+27.6% to +138.0%) | 3.6 |
| Molecular Medicine | 1.78 → 2.42 | +47.9% (+27.5% to +71.5%) | 5.3 |
| Theranostics | 3.14 → 4.04 | +40.0% (+27.1% to +54.2%) | 7.0 |
| Cell Metabolism | 6.22 → 8.52 | +49.1% (+27.0% to +75.0%) | 5.0 |
| Science Translational Medicine | 3.77 → 4.88 | +40.7% (+26.8% to +56.2%) | 6.5 |
| Pharmacological Research | 2.30 → 2.96 | +39.6% (+26.4% to +54.1%) | 6.7 |
| Cellular & Molecular Biology Letters | 2.03 → 3.16 | +69.1% (+25.7% to +127.4%) | 3.5 |
| Inflammatory Bowel Diseases | 1.14 → 1.50 | +43.3% (+25.6% to +63.5%) | 5.4 |
| Neural Regeneration Research | 1.06 → 1.34 | +38.2% (+24.8% to +53.1%) | 6.3 |
| MethodsX | 0.71 → 1.00 | +53.2% (+24.7% to +88.2%) | 4.1 |
| Molecular Diagnosis & Therapy | 0.97 → 1.46 | +64.1% (+24.3% to +116.6%) | 3.6 |
| Cancer Cell International | 1.46 → 1.86 | +38.0% (+24.0% to +53.5%) | 6.0 |
| Current Topics in Medicinal Chemistry | 0.72 → 0.98 | +48.7% (+23.4% to +79.1%) | 4.3 |
| Chinese Medicine | 1.77 → 2.40 | +47.5% (+22.8% to +77.1%) | 4.2 |
| Cell Death and Disease | 2.49 → 3.06 | +33.6% (+22.5% to +45.6%) | 6.7 |
| Journal of Bacteriology | 0.76 → 1.01 | +44.1% (+22.4% to +69.6%) | 4.5 |
| Journal of Experimental & Clinical Cancer Research | 2.98 → 3.65 | +33.5% (+20.6% to +47.8%) | 5.7 |
| Applied Biochemistry and Biotechnology | 0.80 → 1.00 | +36.1% (+20.5% to +53.6%) | 5.1 |
| Nature Reviews Microbiology | 4.44 → 6.92 | +69.6% (+20.3% to +139.2%) | 3.1 |
| Journal of Controlled Release | 2.62 → 3.13 | +29.9% (+20.3% to +40.3%) | 6.8 |
| Neurochemistry International | 1.26 → 1.62 | +39.9% (+20.3% to +62.7%) | 4.4 |
| Burns & Trauma | 2.05 → 2.94 | +56.3% (+19.2% to +105.0%) | 3.3 |
| 动物学研究 | 0.94 → 1.31 | +51.9% (+18.4% to +94.9%) | 3.4 |
| Journal of Orthopaedic Translation | 1.91 → 2.58 | +46.7% (+17.6% to +83.2%) | 3.5 |
| Bone Research | 4.09 → 6.07 | +61.4% (+17.3% to +122.1%) | 3.0 |
| Critical Reviews in Analytical Chemistry | 1.45 → 1.89 | +42.1% (+17.2% to +72.2%) | 3.7 |
| The American Journal of Chinese Medicine | 1.47 → 1.93 | +42.9% (+17.1% to +74.5%) | 3.6 |
| Journal of Translational Medicine | 2.10 → 2.58 | +33.7% (+16.9% to +53.0%) | 4.3 |
| Pathology - Research and Practice | 0.75 → 0.90 | +30.5% (+16.9% to +45.7%) | 4.8 |
| Antibiotics | 1.37 → 1.59 | +26.3% (+16.4% to +37.0%) | 5.7 |
| Cancer Research | 2.14 → 2.62 | +33.0% (+15.9% to +52.6%) | 4.1 |
| Cell Death and Differentiation | 3.03 → 3.98 | +42.6% (+15.9% to +75.5%) | 3.4 |
| Amyloid | 0.56 → 1.04 | +102.1% (+15.5% to +253.9%) | 2.5 |
| BMC Bioinformatics | 0.97 → 1.26 | +40.9% (+15.1% to +72.5%) | 3.4 |
| Current Molecular Medicine | 0.49 → 0.64 | +43.3% (+14.9% to +78.7%) | 3.3 |
| Drug Discovery Today | 2.09 → 2.52 | +31.5% (+14.8% to +50.6%) | 4.0 |
| APOPTOSIS | 1.67 → 2.43 | +58.2% (+14.4% to +118.8%) | 2.8 |
| Digestive and Liver Disease | 0.81 → 0.97 | +31.2% (+14.4% to +50.5%) | 4.0 |
| Pharmaceutics | 1.61 → 1.80 | +21.6% (+14.4% to +29.3%) | 6.4 |
| IEEE Transactions on Computational Biology and Bioinformatics | 0.90 → 1.19 | +43.9% (+14.3% to +81.3%) | 3.2 |
| Pharmaceuticals | 1.54 → 1.75 | +24.0% (+14.1% to +34.8%) | 5.2 |
| Archives of Pharmacal Research | 1.74 → 2.39 | +49.5% (+13.4% to +97.0%) | 2.9 |
| Research | 2.02 → 2.43 | +31.2% (+13.2% to +52.1%) | 3.7 |
| Current Opinion in Structural Biology | 0.49 → 0.58 | +30.2% (+13.0% to +50.1%) | 3.7 |
| Experimental & Molecular Medicine | 3.55 → 4.57 | +40.0% (+12.5% to +74.1%) | 3.1 |
| Chemical Biology & Drug Design | 0.85 → 1.06 | +34.6% (+12.5% to +60.9%) | 3.3 |
| Acta Pharmacologica Sinica | 2.21 → 2.95 | +45.3% (+12.3% to +88.1%) | 2.9 |
| United European Gastroenterology Journal | 1.33 → 1.69 | +38.1% (+12.3% to +69.9%) | 3.1 |
| Biochemical Pharmacology | 1.63 → 1.89 | +26.0% (+12.1% to +41.5%) | 4.0 |
| Animal Cells and Systems | 0.63 → 0.84 | +46.4% (+12.0% to +91.4%) | 2.8 |
| Journal of Ethnopharmacology | 1.79 → 1.95 | +18.7% (+11.3% to +26.7%) | 5.3 |
| Journal of Crohn s and Colitis | 1.78 → 2.26 | +37.9% (+11.2% to +71.1%) | 3.0 |
| International Journal of Biological Sciences | 2.43 → 3.05 | +36.4% (+11.1% to +67.4%) | 3.0 |
| Trends in Molecular Medicine | 1.20 → 1.51 | +36.7% (+11.1% to +68.1%) | 3.0 |
| Archives of Toxicology | 1.73 → 2.76 | +73.4% (+10.8% to +171.5%) | 2.5 |
| FEMS Yeast Research | 0.71 → 0.94 | +44.4% (+10.8% to +88.1%) | 2.8 |
| Biologicals | 0.51 → 0.71 | +50.4% (+10.1% to +105.4%) | 2.6 |
| Computational Biology and Chemistry | 0.80 → 0.96 | +30.6% (+9.8% to +55.2%) | 3.1 |
| Genetic Epidemiology | 0.66 → 1.45 | +137.9% (+9.6% to +416.3%) | 2.2 |
| Molecular Biology Reports | 0.88 → 0.98 | +21.1% (+9.6% to +33.8%) | 3.8 |
| Clinical Science | 1.72 → 2.37 | +49.8% (+9.5% to +104.9%) | 2.6 |
| BMC Microbiology | 1.49 → 1.66 | +21.6% (+9.3% to +35.4%) | 3.7 |
| Cellular and Molecular Gastroenterology and Hepatology | 1.39 → 1.65 | +29.2% (+8.8% to +53.5%) | 3.0 |
| International Immunopharmacology | 1.49 → 1.58 | +15.4% (+7.9% to +23.4%) | 4.3 |
| Microorganisms | 1.49 → 1.59 | +16.2% (+7.8% to +25.3%) | 4.0 |
| Biomedical Reports | 0.72 → 0.88 | +34.0% (+7.6% to +66.9%) | 2.7 |
| Pharmaceutical Biology | 1.41 → 1.63 | +26.0% (+7.5% to +47.6%) | 2.9 |
| Mitochondrion | 1.13 → 1.44 | +39.3% (+7.4% to +80.5%) | 2.6 |
| Cancer Letters | 2.38 → 2.58 | +18.2% (+7.4% to +30.2%) | 3.5 |
| European Journal of Pharmacology | 1.45 → 1.58 | +18.2% (+7.3% to +30.2%) | 3.5 |
| Acta Pharmaceutica Sinica B | 3.24 → 3.79 | +27.2% (+7.0% to +51.2%) | 2.8 |
| Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology | 0.15 → 0.36 | +152.7% (+6.7% to +498.3%) | 2.2 |
| Molecular and Cellular Biochemistry | 1.16 → 1.30 | +22.3% (+6.6% to +40.2%) | 2.9 |
| Physiological Research | 0.70 → 0.86 | +34.3% (+6.6% to +69.3%) | 2.6 |
| SLAS TECHNOLOGY | 0.67 → 0.96 | +56.9% (+6.4% to +131.5%) | 2.3 |
| Journal of Biomedical Science | 3.11 → 4.17 | +45.9% (+6.3% to +100.3%) | 2.4 |
| Combinatorial Chemistry & High Throughput Screening | 0.40 → 0.47 | +26.7% (+6.3% to +51.1%) | 2.7 |
| Journal of Microbiology and Biotechnology | 0.85 → 1.04 | +33.0% (+6.1% to +66.8%) | 2.5 |
| PROTEOMICS - CLINICAL APPLICATIONS | 0.63 → 0.89 | +53.5% (+6.0% to +122.2%) | 2.3 |
| Clinical and Translational Medicine | 1.54 → 1.77 | +25.1% (+6.0% to +47.7%) | 2.7 |
| Trends in Genetics | 0.83 → 1.12 | +47.2% (+5.8% to +104.7%) | 2.3 |
| Enzyme and Microbial Technology | 0.84 → 0.96 | +24.2% (+5.7% to +45.9%) | 2.7 |
| Chemico-Biological Interactions | 1.45 → 1.65 | +24.2% (+5.6% to +46.2%) | 2.7 |
| Inflammation | 1.43 → 1.65 | +25.3% (+5.3% to +49.0%) | 2.6 |
| FEMS Microbiology Reviews | 3.46 → 4.53 | +42.4% (+4.8% to +93.4%) | 2.3 |
| Microbial Pathogenesis | 1.16 → 1.24 | +16.2% (+4.1% to +29.7%) | 2.7 |
| Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics | 0.87 → 1.04 | +29.9% (+3.8% to +62.5%) | 2.3 |
| Current Microbiology | 0.80 → 0.86 | +17.4% (+3.5% to +33.2%) | 2.5 |
| ACS Infectious Diseases | 1.24 → 1.36 | +18.9% (+3.4% to +36.7%) | 2.5 |
| Biotechnology and Applied Biochemistry | 0.68 → 0.79 | +24.9% (+3.3% to +51.1%) | 2.3 |
| Basic & Clinical Pharmacology & Toxicology | 0.86 → 1.05 | +32.8% (+3.2% to +71.0%) | 2.2 |
| Advanced Drug Delivery Reviews | 1.38 → 1.51 | +19.2% (+3.1% to +37.7%) | 2.4 |
| Antioxidants | 2.29 → 2.33 | +10.3% (+2.8% to +18.3%) | 2.8 |
| Pharmacology & Therapeutics | 3.55 → 3.97 | +21.6% (+2.7% to +44.1%) | 2.3 |
| Journal of Pharmaceutical Sciences | 0.85 → 0.91 | +17.2% (+2.6% to +33.7%) | 2.4 |
| Biochemical Journal | 0.98 → 1.15 | +26.9% (+2.6% to +57.0%) | 2.2 |
| Turkish Journal of Biochemistry | 0.22 → 0.28 | +36.8% (+2.4% to +82.6%) | 2.2 |
| Bioprocess and Biosystems Engineering | 0.90 → 1.00 | +22.0% (+2.4% to +45.4%) | 2.3 |
| Archives of Microbiology | 0.89 → 0.95 | +15.4% (+2.2% to +30.4%) | 2.4 |
| Biochemical Society Transactions | 1.19 → 1.28 | +17.2% (+2.1% to +34.4%) | 2.3 |
| Current Neuropharmacology | 1.32 → 1.51 | +24.2% (+2.0% to +51.2%) | 2.2 |
| Trends in Cell Biology | 1.34 → 1.61 | +31.4% (+1.9% to +69.4%) | 2.2 |
| Journal of Advanced Research | 2.98 → 3.73 | +35.9% (+1.6% to +81.8%) | 2.1 |
| Journal of genetics and genomics/Journal of Genetics and Genomics | 1.19 → 1.57 | +43.4% (+1.5% to +102.5%) | 2.1 |
| Biomarker Research | 2.76 → 3.33 | +30.9% (+1.4% to +69.1%) | 2.1 |
| Nature Biomedical Engineering | 5.03 → 5.61 | +21.4% (+1.1% to +45.7%) | 2.1 |
| Journal of Eukaryotic Microbiology | 0.56 → 0.74 | +43.7% (+0.8% to +105.0%) | 2.0 |
| Journal of Clinical Laboratory Analysis | 0.77 → 0.95 | +34.5% (+0.7% to +79.6%) | 2.0 |
| Oncogene | 2.11 → 2.17 | +11.7% (+0.6% to +24.2%) | 2.1 |
| Progress in Biophysics and Molecular Biology | 1.00 → 1.23 | +34.0% (+0.5% to +78.8%) | 2.0 |
| The Kaohsiung Journal of Medical Sciences | 0.72 → 0.80 | +21.9% (+0.1% to +48.5%) | 2.0 |
| Cellular Signalling | 1.23 → 1.25 | +10.8% (+0.1% to +22.7%) | 2.0 |
| Microbial Biotechnology | 1.44 → 1.60 | +21.4% (+0.01% to +47.5%) | 2.0 |
How to read this list
Relative change = journal OJR ratio ÷ median group ratio − 1. The journal ratio is its OJR in 2025 divided by its OJR in 2022. The group ratio is the median of those ratios among eligible journals of the field, taken on a log scale: with an even number of journals, it is the geometric mean of the two middle ratios rather than their average.
Indicator year 2022 counts citations to papers published 2019–2021; indicator year 2025 counts citations to papers published 2022–2024. The two publication cohorts do not overlap.
A journal is listed when it is ranked, its relative change is +10% or more, and the change is at least 2 standard errors above zero (z ≥ 2), so the low end of its two-standard-error range is zero or above.
The top journal’s OJR rose from 4.84 to 14.09, starting above the world average of 1.00. Relative to the median journal of its field, its change was +216.6%.